ORAL ANTIHISTAMINE OR NASAL STEROID IN HAY-FEVER - A DOUBLE-BLIND DOUBLE-DUMMY COMPARATIVE-STUDY OF ONCE DAILY ORAL ASTEMIZOLE VS TWICE DAILY NASAL BECLOMETHASONE DIPROPIONATE

被引：42
|
作者：
WOOD, SF
机构：
来源：
CLINICAL ALLERGY | 1986年 / 16卷 / 03期
关键词：
D O I：
10.1111/j.1365-2222.1986.tb00766.x
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：195 / 201
页数：7
相关论文
共 50 条
  • [1] A COMPARATIVE-STUDY OF ORAL ASTEMIZOLE AND NASAL BECLOMETHASONE IN HAY-FEVER
    WOOD, SF
    ANNALS OF ALLERGY, 1985, 55 (02): : 253 - 253
  • [2] EFFICACY OF AN ORAL ANTIHISTAMINE, ASTEMIZOLE, AS COMPARED TO A NASAL STEROID SPRAY IN HAY-FEVER
    SALOMONSSON, P
    GOTTBERG, L
    HEILBORN, H
    NORRLIND, K
    PEGELOW, KO
    ALLERGY, 1988, 43 (03) : 214 - 218
  • [3] MULTICENTER DOUBLE-BLIND COMPARISON OF TERFENADINE ONCE DAILY VERSUS TWICE DAILY IN PATIENTS WITH HAY-FEVER
    HENAUER, S
    HUGONOT, L
    HUGONOT, R
    KURZEJA, A
    GASTPAR, H
    RAUCHRIEDELSHEIMER, B
    BEAUMONT, D
    KOHLER, M
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1987, 15 (04) : 212 - 223
  • [4] MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY OF TERFENADINE AND CETIRIZINE IN HAY-FEVER
    CAIAFFA, MF
    IUDICE, A
    MACCHIA, L
    TURSI, A
    VERGALLO, G
    SACERDOTI, G
    VENUTI, A
    DELLATORRE, F
    MUSARRA, A
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1992, 2 (03): : 162 - 166
  • [5] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TIPREDANE NASAL SPRAY IN HAY-FEVER
    STERN, MA
    DARNELL, R
    POWELL, RJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (10): : 997 - 997
  • [6] THE EFFICACY OF ORAL IMMUNOTHERAPY IN PATIENTS WITH SEASONAL HAY-FEVER - A DOUBLE-BLIND STUDY
    VANNIEKERK, CH
    ANNALS OF ALLERGY, 1985, 55 (02): : 259 - 259
  • [7] A DOUBLE-BLIND COMPARISON OF THE EFFICACY OF BETAMETHASONE DIPROPIONATE CREAM TWICE DAILY VERSUS ONCE DAILY IN THE TREATMENT OF STEROID RESPONSIVE DERMATOSES
    ENGLISH, JSC
    BUNKER, CB
    RUTHVEN, K
    DOWD, PM
    GREAVES, MW
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1989, 14 (01) : 32 - 34
  • [8] Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
    Dignass, Axel
    Stoynov, Simeon
    Dorofeyev, Andrey E.
    Grigorieva, Galina A.
    Tormova, Eva
    Altorjay, Istvan
    Tuculanu, Daniel
    Bunganic, Ivan
    Pokrotnieks, Juris
    Kupcinskas, Limas
    Dilger, Karin
    Greinwald, Roland
    Mueller, Ralph
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (09): : 970 - 980
  • [9] Oral once daily budesonide granules rapidly induce clinical remission in Lymphocytic Colitis: A double-blind, double-dummy, multi-centre, randomised trial
    Miehlke, S.
    Aust, D.
    Mihaly, E.
    Armerding, P.
    Boehm, G.
    Bonderup, O.
    Fernandez-Banares, F.
    Kupcinskas, J.
    Munck, L. K.
    Rehbehn, K. -U.
    Nacak, T.
    Greinwald, R.
    Muench, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S491 - S491
  • [10] ORAL ONCE DAILY BUDESONIDE GRANULES INDUCE CLINICAL REMISSION IN LYMPHOCYTIC COLITIS AND IMPROVE QUALITY OF LIFE: A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY MULTICENTER TRIAL
    Miehlke, Stephan
    Aust, Daniela
    Mihaly, Emese
    Amerding, Peter
    Boehm, Guenter
    Bonderup, Ole
    Fernandez-Banares, Fernando
    Kupcinskas, Juozas
    Munck, Lars Kristian
    Rehbehn, Kai-Uwe
    Nacak, Tanju
    Greinwald, Roland
    Munch, Andreas
    GASTROENTEROLOGY, 2018, 154 (06) : S168 - S169
12345